Skip to Content

Enterprise software company ­Veeva has become an indispensable nucleus for the life sciences industry, helping Big Pharma manage customer databases, track drug developments, and organize clinical trials. Revenues rose by 33% last year to $544 million, as the likes of Abbott, [f500link]Merck[/f500link], and [f500link]Pfizer[/f500link] employed a suite of its cloud-based offerings. Vault, its new content management system, is already being used by 35 of the top 50 pharma companies. The platform could help Veeva take a bigger chunk of the global life sciences applications market, forecast to reach $6.8 billion in sales by 2020.

Company Information

Overall Score4.5
Sector
Technology
Industry
Computer Software
CEO
Peter P. Gassner
Websitehttp://www.veeva.com
Employees1,794
HQ Location
Pleasanton, Calif.
Revenues ($M) (Past 12 Months)$617
Profits ($M) (Past 12 Months)$117
Market Value as of Oct. 9, 2017 ($M)$8,170